Heath, Madison R.
Mujagic, Zlatan
Luo, Yuying
Keszthelyi, Daniel
Article History
Received: 3 February 2025
Accepted: 25 February 2025
First Online: 8 March 2025
Declarations
:
: The authors have no conflicts of interest related to the current commentary. Other disclosers: Zlatan Mujagic received grants: ZonMw, Niels Stensen Fellowship, MLDS, Top consortium for Knowledge and Innovation (TKI) and Galapagos, advisory board fees: Johnson & Johnson, Eli Lilly, Pfizer (paid to host institution), and speaker’s fees: Friso—Friesland Campina, Galapagos, Eli Lilly and Takeda (paid to host institution). Daniel Keszthelyi has received grants from UEG, MLDS, ZonMw, Horizon 2020, Horizon Europe, Rome Foundation and speaker’s fee from Rome Foundation (paid to host institute).
Free to read: This content has been made available to all.